TIM-3 could also inhibit the killing effect of Vγ9Vδ2 T cells on tumor by reducing the expression of perforin and granzyme B. PD-1 and TIM-3 antibodies could protect anti-tumor activity of Vγ9Vδ2 T cells (186–188). This evidence concerns the gene PRF1 and neoplasm.